Treatment of a metabolic disorder

Details for Australian Patent Application No. 2011214440 (hide)

Owner Glaxo Group Limited

Inventors Bayliffe, Andrew Ian

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011214440

PCT Pub. Number WO2011/098424

Priority 61/302,637 09.02.10 US

Filing date 7 February 2011

Wipo publication date 18 August 2011

International Classifications

C07K 16/24 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 3/00 Drugs for disorders of the metabolism

A61P 3/04 Drugs for disorders of the metabolism

A61P 3/10 Drugs for disorders of the metabolism

Event Publications

30 August 2012 PCT application entered the National Phase

  PCT publication WO2011/098424 Priority application(s): WO2011/098424

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011214462-Device for smoking cessation and use of such a device

2011214423-Method for the preparation of rivaroxaban